Annika N. Alexopoulou

Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy

Bernardo Tavora, Louise E. Reynolds, Sílvia Batista et al. · Nature · 2014 · 163 citations

Medicine, Cancer Biology, Oncology +16

The CMV early enhancer/chicken β actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors

Annika N. Alexopoulou, John Couchman, James R. Whiteford · BMC Cell Biology · 2008 · 125 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17

Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines

Annika N. Alexopoulou, Maria Leao, Otávia L. Caballero et al. · Breast Cancer Research · 2010 · 75 citations · Full text

Medicine, Molecular Biology, Oncology +17

Tumor Angiogenesis Is Differentially Regulated by Phosphorylation of Endothelial Cell Focal Adhesion Kinase Tyrosines-397 and -861

Ana‐Rita Pedrosa, Natalia Bodrug, Jesús Gómez-Escudero et al. · Cancer Research · 2019 · 57 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Focal Adhesion Kinase (FAK) tyrosine 397E mutation restores the vascular leakage defect in endothelium‐specific FAK‐kinase dead mice

Annika N. Alexopoulou, Delphine M. Lees, Natalia Bodrug et al. · The Journal of Pathology · 2017 · 25 citations · Full text

Life Sciences, Cell Biology, Oncology +14